Therapy News and Research

RSS

Study results of Cameron Health's S-ICD- System published online in NEJM

Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine highlighting the development and potential benefits of the company's S-ICD- System, the first minimally invasive, subcutaneous implantable cardioverter defibrillator, for the treatment of sudden cardiac arrest.

14 May 2010

Minnesota lawmakers debate budget, Medicaid expansion

More budget talks were expected Thursday as Minnesota's legislative session hurtled toward a midnight Sunday deadline with no deal on a $3 billion deficit. The Democratic-controlled Legislature defied another veto threat from Republican Gov. Tim Pawlenty late Wednesday and sent him a health and welfare package he opposes.

14 May 2010

Nephros reports 57% increase in revenues for first-quarter 2010

Nephros, Inc. announced today financial results for the three months ended March 31, 2010.

14 May 2010

Fibrocell Science commences histology study of azficel-T for treatment of nasolabial fold wrinkles

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.

14 May 2010

New Infrared Relief therapy now available for patients with diabetic neuropathies

Genesis Spine Associates now offers Infrared Relief - a new, highly effective pain management therapy using infrared light for patients suffering from diabetic neuropathies. This new therapy offers a simple, painless option for managing patients' pain without potentially dangerous drugs or surgery.

14 May 2010

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

HIV disease tends to progress at a faster rate in infected individuals who consume two or more alcoholic drinks a day, according to an important new paper in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 May 2010

Chimerix commences first-in-human study of CMX157 for HIV

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.

14 May 2010

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Boston Scientific Corporation today announced U.S. Food and Drug Administration clearance of the ACUITY Break-Away Lead Delivery System for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure.

14 May 2010

Home health care stocks fall with Senate Finance Committee inquiry

Shares of four home health care providers tumbled Thursday after the Senate Finance Committee raised questions about how the companies bill Medicare for home health therapy visits, The Associated Press/ABC News reports.

14 May 2010

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

ARYx Therapeutics, Inc. today reported results of operations and provided an update on its business activities for the first quarter ended March 31, 2010.

13 May 2010

Gene-Eden may be effective in reducing Hepatitis C viral load in people infected with virus: Review

A new review on the Amazon website suggests that the natural antiviral supplement Gene-Eden may be effective in reducing the Hepatitis C viral load in people infected with the virus.

13 May 2010

First Edition: May 13, 2010

Among today's headlines are reports that some Republican senators are taking aim at President Obama's pick to run the Centers for Medicare and Medicaid Services.

13 May 2010

Researchers provide better understanding of anti-cell death proteins and potential antagonist to defeat them

Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.

13 May 2010

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

Graymark Healthcare, Inc. today announced progress on Fiscal 2010 Initiatives and financial results for the Quarter ending March 31, 2010.

13 May 2010

Adults with SCA show poorer performance on neurocognitive tests: Study

Compared with a group of healthy study participants, adults with sickle cell anemia showed poorer performance on neurocognitive tests, which was associated with anemia and age, according to a study in the May 12 issue of JAMA.

13 May 2010

No clear consensus on prevalence, diagnosis, management, and prevention of food allergies

A review of previous research indicates that there are few high-quality studies on food allergies, with limited uniform criteria for making a diagnosis and determining prevalence and effective treatments, according to an article in the May 12 issue of JAMA.

13 May 2010

Pain rehabilitation programs can help patients break the cycle of worsening pain: Mayo Clinic Health Letter

Chronic pain -- whether from headaches, back pain or conditions such as fibromyalgia -- can interfere with work, day-to-day activities and relationships. All too often, pain relief treatments are ineffective and can lead to a downward spiral of frustration, decreased functioning, stress, isolation -- and worsening pain.

13 May 2010

Increased IR associated with HCC development in chronic HCV-infected patients

Recent studies have demonstrated that type 2 diabetes mellitus (DM) is associated with high risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C. Insulin resistance (IR), which correlates inversely with circulating adiponectin concentration, is a consistent finding in patients with type 2 DM.

13 May 2010

Research investigates MDR in human HCC

Hepatocellular carcinoma responds poorly to chemotherapy owing to MDR. Recent studies have shown the tumors derived from the colon, kidney, or adrenal cortex, and HCC exhibited overexpression of MDR1/P-gp. This overexpression results in a primary MDR phenotype of these cancers.

13 May 2010

Cognitive strategies lessen depression symptoms: Study

Moderate to severely depressed clients showed greater improvement in cognitive therapy when therapists emphasized changing how they think rather than how they behave, new research has found.

13 May 2010

Therapy News and Research

Study results of Cameron Health's S-ICD- System published online in NEJM

Minnesota lawmakers debate budget, Medicaid expansion

Nephros reports 57% increase in revenues for first-quarter 2010

Fibrocell Science commences histology study of azficel-T for treatment of nasolabial fold wrinkles

New Infrared Relief therapy now available for patients with diabetic neuropathies

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

Chimerix commences first-in-human study of CMX157 for HIV

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Home health care stocks fall with Senate Finance Committee inquiry

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

Gene-Eden may be effective in reducing Hepatitis C viral load in people infected with virus: Review

First Edition: May 13, 2010

Researchers provide better understanding of anti-cell death proteins and potential antagonist to defeat them

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

Adults with SCA show poorer performance on neurocognitive tests: Study

No clear consensus on prevalence, diagnosis, management, and prevention of food allergies

Pain rehabilitation programs can help patients break the cycle of worsening pain: Mayo Clinic Health Letter

Increased IR associated with HCC development in chronic HCV-infected patients

Research investigates MDR in human HCC

Cognitive strategies lessen depression symptoms: Study

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News